Covenant Asset Management, LLC Amgen Inc Transaction History

Covenant Asset Management, LLC

$631 Million
Q3 2024

A detailed history of Covenant Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Covenant Asset Management, LLC holds 5,255 shares of AMGN stock, worth $1.38 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

5,255

Previous 5,461 3.77%

Holding current value

$1.38 Million

Previous $1.71 Million 0.76%

% of portfolio

0.27%

Previous 0.27%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $63,732 - $69,500	-206 Reduced 3.77%	5,255 $1.69 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $117,974 - $143,370	449 Added 8.96%	5,461 $1.71 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $69,637 - $84,061	259 Added 5.45%	5,012 $1.43 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $52,418 - $59,134	-205 Reduced 4.13%	4,753 $1.37 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $6,778 - $8,415	31 Added 0.63%	4,958 $1.33 Million
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $8,570 - $10,134	40 Added 0.82%	4,927 $1.09 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $53,286 - $64,947	236 Added 5.07%	4,887 $1.18 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $9,161 - $11,640	-40 Reduced 0.85%	4,651 $0
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $20,874 - $23,542	-93 Reduced 1.94%	4,691 $1.06 Million
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $14,073 - $15,661	61 Added 1.29%	4,784 $1.16 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $9,347 - $10,697	47 Added 1.01%	4,723 $1.06 Million
Q3 2021 Oct 15, 2021	SELL	$212.27 - $248.7 $7,641 - $8,953	-36 Reduced 0.76%	4,676 $994,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $28,404 - $33,100	128 Added 2.79%	4,712 $1.17 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $100,833 - $120,074	466 Added 11.32%	4,584 $1.05 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $76,261 - $84,808	-325 Reduced 7.31%	4,118 $1.05 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $267,241 - $327,941	1,351 Added 43.69%	4,443 $1.05 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $95,858 - $127,134	526 Added 20.5%	3,092 $627,000
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $21,191 - $27,238	-112 Reduced 4.18%	2,566 $619,000
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $14,277 - $17,106	82 Added 3.16%	2,678 $518,000
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $19,170 - $22,472	115 Added 4.64%	2,596 $478,000
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $38,887 - $43,834	-215 Reduced 7.97%	2,481 $471,000
Q3 2018 Oct 09, 2018	BUY	$185.29 - $208.89 $8,338 - $9,400	45 Added 1.7%	2,696 $559,000
Q2 2018 Jul 12, 2018	BUY	$166.05 - $186.51 $5,313 - $5,968	32 Added 1.22%	2,651 $489,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $66,924 - $78,210	395 Added 17.76%	2,619 $446,000
Q4 2017 Jan 12, 2018	BUY	$168.79 - $188.59 $57,557 - $64,309	341 Added 18.11%	2,224 $387,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $315,007 - $359,653	1,883	1,883 $351,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.

Account

Covenant Asset Management, LLC Amgen Inc Transaction History